Identification of Renal Injury in Cardiac Surgery: The Role of Kidney-Specific Proteins

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 1, 2008, Pages 122-132

  Boldt, Joachim ^a   Wolf, Michael ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

cardiac surgery; kidney function; kidney specific proteins; Medline; outcome

Indexed keywords

BIOLOGICAL MARKER; DEXAMETHASONE; DOPAMINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PENTOXIFYLLINE;

CARDIOPULMONARY BYPASS; CLINICAL STUDY; CLINICAL TRIAL; GLOMERULUS FILTRATION RATE; HEART SURGERY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ACUTE-PHASE PROTEINS; AGE FACTORS; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CREATININE; CYSTATINS; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; LIPOCALINS; MEMBRANE GLYCOPROTEINS; NEPRILYSIN; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 38949135489     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.10.008     Document Type: Review

References (81)

1. Aronson S., and Blumenthal R. Perioperative renal dysfunction and cardiovascular anesthesia: Concerns and controversies. J Cardiothorac Vasc Anesth 12 (1998) 567-586
2. Simmons P.I., and Anderson R.J. Increased serum creatinine: A marker for adverse outcome before and after cardiac surgery. Crit Care Med 30 (2002) 1664-1665
3. Conlon P.J., Stafford-Smith M., White W.D., et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14 (1999) 1158-1162
4. Yallop K.G., and Smith D. The incidence and pathogenesis of acute renal failure following cardiac surgery, and strategies for its prevention. Ann Cardiac Anaesth 7 (2004) 17-31
5. Chertow G.M., Burdick E., Honour M., et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005) 3365-3370
6. Lassnigg A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol 15 (2004) 1597-1605
7. Wagener G., Jan M., Kim M., et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105 (2006) 485-491
8. Han W.K., and Bonventre J.V. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 10 (2004) 476-482
9. Bellomo R., Kellum J.A., and Ronco C. Defining acute renal failure: Physiological principles. Intensive Care Med 30 (2004) 33-37
10. Lameire N., and Hoste E. Reflections on the definition, classification, and diagnostic evaluation of acute renal failure. Curr Opin Crit Care 10 (2004) 468-475
11. Bellomo R., Ronco C., Kellum J.A., et al., ADQI workgroup. Acute renal failure-Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 (2004) R204-R212
12. Byrick R.J., and Rose D.K. Review article: Pathophysiology and prevention of acute renal failure: The role of the anaesthetist. Can J Anaesth 37 (1990) 457-467
13. Butler R., Rocker G.M., and Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55 (1993) 552-559
14. Gormley S.M.C., McBride W.T., Armstrong M.A., et al. Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology 93 (2000) 1210-1216
15. Baker R.C., Armstrong M.A., and Allen S.J. Role of the kidney in the perioperative inflammatory response. Br J Anaesth 88 (2002) 330-334
16. Chertow G.M., Lazerus J.M., Christiansen C.L., et al. Preoperative renal risk stratification. Circulation 95 (1997) 878-884
17. Mangano C.M., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128 (1998) 194-203
18. Sear J.W. Kidney dysfunction in the postoperative period. Br J Anaesth 95 (2005) 20-32
19. Stevens L.A., Coresh J., Greene T., et al. Assessing kidney function-Measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
20. Rosner M.H.O., and Mark D. Acute kidney injury associated with cardiac sugery. Clin J Am Nephrol 1 (2006) 19-32
21. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
22. Shlipak M.G., Katz R., Sarnak M.J., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
23. Randers E., and Erlandsen E.J. Serum cystatin C as an endogenous marker of renal dysfunction: A review. Clin Chem Lab Med 37 (1999) 389-395
24. Hojs R., Bevc S., Ekart R., et al. Serum cystatin C as an endogenous marker of renal function in patients with mild-to-moderate impairment of kidney function. Nephrol Dial Transplant 8 (2006) 1-8
25. Page M.K., Bukki J., Luppa P., et al. Clinical value of cystatin C determination. Clin Chim Acta 297 (2006) 67-72
26. Dharnidharka V.R., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 40 (2002) 221-226
27. Grubb A.O. Cystatin C-Properties and use as diagnostic marker. Adv Clin Chem 35 (2000) 63-99
28. Laterza O.F., Price C.P., and Scott M.G. Cystatin C: an improved estimator of glomerular filtration rate?. Clin Chem 48 (2002) 699-707
29. Higgins T.L. Postoperative complications and ICU. In: Estafanous F.G., Barash P.G., and Reves J.G. (Eds). Cardiac Anesthesia (1994), JB Lippincott, Philadelphia, PA 373-402
30. Davila-Roman V.G., Kouchoukos N.T., Schechtman K.B., et al. Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 117 (1999) 111-116
31. Ryckwaert F., Boccara G., Frappier J.M., et al. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med 30 (2002) 1495-1498
32. Provenchere S., Plantefeve G., Hufnagel G., et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: Incidence, risk factors, and effect on clinical outcome. Anesth Analg 96 (2003) 1258-1264
33. Heringlake M., Knappe M., Vargas-Hein O., et al. Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol 72 (2006) 645-654
34. Kuitunen A., Vento A., Suojaranta-Ylinen R., et al. Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 81 (2006) 542-546
35. Herget-Rosenthal S. One step forward in the early detection of acute renal failure. Lancet 363 (2005) 1205-1206
36. Mantur M., Kaemona H., Dabrowsky M., et al. Alpha1-microglobulin as a marker of proximal tubular damage in urinary tract infection in children. Clin Nephrol 53 (2000) 283-287
37. Hewitt S.M., Dear J., and Star R.A. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 15 (2004) 1677-1679
38. Ichimura T., Bonventre J.V., Bailly V., et al. Kidney Injury Molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is upregulated in renal cells after injury. J Biol Chem 273 (1998) 4135-4142
39. Han W.K., Bailly V., Abichandani R., et al. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62 (2002) 237-244
40. Torffvit O., Kamper A.L., and Strandgaard S. Tamm-Horsfall protein in urine after uninephrectomy/transplantation in kidney donors and their recipients. Scand J Urol Nephrol 31 (1997) 555-559
41. Kjeldsen L., Cowland J.B., and Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mice. Biochem Biophys Acta 1482 (2000) 272-283
42. Mishra J., Ma Q., Prada A., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 14 (2003) 2534-2543
43. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005) 1231-1238
44. Usuda K., Kono K., Dote T., et al. Urinary biomarkers monitoring for experimental fluoride nephrotoxicity. Arch Toxicol 72 (1998) 104-109
45. Branten A.J., Mulder T.P., Peters W.H., et al. Urinary excretion of glutathione S transferases alpha and pi in patients with proteinuria: Reflection of the site of tubular injury. Nephron 85 (2000) 120-126
46. Sundberg A.G.M., Appelkvist E.L., Bäckman L., et al. Quantitation of glutathione transferase-Pi in the urine by radioimmunoassay. Nephron 66 (1994) 162-169
47. Westhuyzen J., McGiffin D.C., McCarthy J., et al. Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 228 (1994) 123-132
48. Gormley S.M., McBride W.T., Armstrong M.A., et al. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Cytokine 17 (2002) 61-65
49. Bergman A.S.F., Odar-Cederlöf I., Westman L., et al. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth 16 (2002) 294-299
50. Jung K., and Becker S. Multiple forms of N-acetyl-beta-D-glucosaminidase of human urine: isolation, properties and the development of a practical approach of differentiation. Biomed Biochim Acta 50 (1991) 861-567
51. Westhuyzen J., Endre Z.H., Reece G., et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 18 (2003) 543-551
52. Flynn F.V. Assessment of renal function: selected developments. Clin Biochem 23 (1990) 49-54
53. Tang A.T., El-Gamel A., Keevil B., et al. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP). Eur J Cardiothorac Surg 15 (1999) 717-721
54. Sumeray M., Robertson C., Lapsley M., et al. Low-dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery. J Nephrol 14 (2001) 397-402
55. Tang A.T., Knott J., Nanson J., et al. A prospective randomized study to evaluate the renoprotective action of beating heart coronary surgery in low-risk patients. Eur J Cardiothorac Surg 22 (2002) 118-123
56. Woo E.B., Tang A.T., el-Gamel A., et al. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: Science or fiction?. Eur J Cardiothorac Surg 22 (2002) 106-111
57. Blaikley J., Sutton P., Walter M., et al. Tubular proteinuria and enzymuria following open heart surgery. Intensive Care Med 29 (2003) 1364-1367
58. Ip-Yam P.C., Murphy S., Baines M., et al. Renal function and proteinuria after cardiopulmonary bypass: The effects of temperature and mannitol. Anesth Analg 78 (1994) 842-847
59. Lema G., Meneses G., Urzua J., et al. Effects of extracorporeal circulation on renal function in coronary surgical patients. Anesth Analg 81 (1995) 446-451
60. Hamada Y., Kanda T., Anzai T., et al. N-acetyl-beta-D-glucosaminidase is not a predictor, but an indicator of kidney injury in patients with cardiac surgery. J Med 30 (1999) 329-336
61. Loef B.G., Epema A.H., Navis G., et al. Off-pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization. Chest 121 (2002) 1190-1194
62. Loef B.G., Henning R.H., Epema A.H., et al. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 93 (2004) 793-798
63. Morariu A.M., Loef B.G., Aarts L.P., et al. Dexamethasone: Benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: A study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 128 (2005) 2677-2687
64. Boldt J., Brosch C., Piper S.N., et al. Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 29 (2001) 952-958
65. Boldt J., Brosch C., Suttner S., et al. Prophylactic use of the phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients: Effect on hemodynamics, inflammation, and markers of organ function. Intensive Care Med 28 (2002) 1462-1469
66. Abe K., Sakakibara T., and Yoshiya I. The effect of prostaglandin E1 on renal function after cardiac surgery involving cardiopulmonary bypass. Prostaglandins Leukot Essent Fatty Acids 49 (1993) 627-631
67. Jorres A., Kordonouri O., Schiessler A., et al. Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 18 (1994) 565-569
68. Ascione R., Lloyd C.T., Underwood M.J., et al. On-pump versus off-pump coronary revascularization: Evaluation of renal function. Ann Thorac Surg 68 (1999) 493-498
69. Gormley S.M., McBride W.T., Armstrong M.A., et al. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Cytokine 17 (2002) 61-65
70. Boldt J., Brenner T., Lang J., et al. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg 97 (2003) 1582-1589
71. Fauli A., Gomar C., Campistol J.M., et al. Pattern of renal dysfunction associated with myocardial revascularization surgery and cardiopulmonary bypass. Eur J Anaesthesiol 20 (2003) 443-450
72. McBride W.T., Allen S., Gormley S.M., et al. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery. Cytokine 27 (2004) 81-89
73. Abu-Omar Y., Mussa S., Naik M.J., et al. Evaluation of cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery. Eur J Cardiothorac Surg 27 (2005) 893-898
74. Fauli A., Gomar C., Campistol J.M., et al. Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass. Eur J Anaesthesiol 22 (2005) 666-671
75. Eijkenboom J.J., van Eijk L.T., Pickkers P., et al. Small increases in the urinary excretion of glutathione S-transferase A1 and P1 after cardiac surgery are not associated with clinically relevant renal injury. Intensive Care Med 31 (2005) 664-667
76. Piper S.N., Kumle B., Maleck W.H., et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth 50 (2003) 285-292
77. Boldt J., Brenner T., Lehmann A., et al. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: Comparison of a new starch preparation with gelatin. Intensive Care Med 29 (2003) 763-769
78. Boldt J., Brenner T., Lehmann A., et al. Is kidney function altered by the duration of cardiopulmonary bypass?. Ann Thorac Surg 75 (2003) 906-912
79. Wijeysundera D.N., Karkouti K., Beattie W.S., et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 104 (2006) 65-72
80. Kellum J.A., Levin N., Bouman C., et al. Developing consensus classification system for acute renal failure. Curr Opin Crit Care 8 (2002) 509-514
81. Wijeysundera D.N., Rao V., Beattie W.S., et al. Evaluating surrogate measures of renal dysfunction after cardiac surgery. Anesth Analg 96 (2003) 1265-1273